Directory Search

Qiagen Pty Ltd

QIAGEN is the leading provider of sample and assay technologies. Sample technologies are used to isolate DNA, RNA, and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis.

Phone: 03 9840 9800
Fax: 03 9840 9888
Level 1, 90-94 Tram Road , Doncaster VIC 3108 (Directions)


QIAGEN QIAprep&amp CRISPR Kit and CRISPR Q-Primer Solutions

QIAGEN's QIAprep&amp CRISPR Kit and CRISPR Q-Primer Solutions allow researchers to analyse edited genetic material with speed and efficiency to determine how their interventions have changed the function of the DNA sequence in question.

QIAGEN QIAstat-Dx syndromic testing instrument

Using direct swab or liquid transfer, the QIAstat-Dx provides results for 20+ respiratory or gastrointestinal pathogens in about 1 h, with less than 1 min of hands-on time.

QIAGEN Investigator human identity testing products

QIAGEN's Investigator kits rapidly generate DNA profiles from blood, buccal swabs and forensic stains.

QIAGEN Clinical Insight bioinformatics platform expanded

The QIAGEN Clinical Insight (QCI) clinical decision support solution streamlines the annotation, interpretation and reporting of next-generation sequencing results (NGS) for clinical laboratories. The bioinformatics platform has been expanded from interpreting NGS data on somatic mutations in solid tumour cancers to add leukaemia and lymphoma testing, as well as testing for hereditary cancer indications.

QIAGEN GeneReader NGS System

QIAGEN has announced the start of commercialisation activities for its GeneReader NGS System, a Sample to Insight next-generation sequencing (NGS) solution that enables laboratories to deliver actionable results. The system offers an end-to-end NGS workflow from primary sample to a final report that provides a simple way for clinical testing to take advantage of NGS technology and improve outcomes.

QIAGEN Clinical Insight bioinformatics platform

QIAGEN has announced the launch of the QIAGEN Clinical Insight (QCI) bioinformatics content and software platform for clinical testing labs to interpret and report on genomic variants identified in next-generation sequencing (NGS).

Qiagen QuantiFERON Monitor for tracking immune function in solid organ transplant patients

Qiagen has announced the QuantiFERON Monitor (QFM), a novel diagnostic for monitoring immune function. It is available in non-European markets for research use as an accurate marker of immune function in studies of immunosuppressive conditions, immune modulating therapies and recovery following transplantation.

altona Diagnostic RealStar Ebolavirus RT-PCR Kit 1.0

The altona Diagnostics RealStar Ebolavirus RT-PCR Kit 1.0 is a reverse transcription polymerase chain reaction (RT-PCR) test intended for the qualitative detection of RNA from all known strains of Ebolaviruses, including the Zaire strain driving the current Ebola epidemic in West Africa.

Qiagen GeneRead DNAseq Leukemia V2 gene panel with SF3B1 biomarker

Qiagen has acquired an exclusive global licence to the biomarker SF3B1 from the University of Tokyo. The biomarker is included in the company's GeneRead DNAseq Leukemia V2 gene panel for next-generation sequencing.

Qiagen GeneRead DNAseq V2 gene panels

Qiagen has launched 14 GeneRead DNAseq V2 gene panels targeting an extensive range of cancer-related genes and gene regions, including 'focused' panels each targeting 8-25 genes, 'disease-specific' panels for 40-50 genes and 'comprehensive' panels for as many as 160 genes.

Qiagen artus CMV RGQ MDx Kit

Qiagen's artus CMV RGQ MDx Kit for human cytomegalovirus (CMV) has been approved by the US Food and Drug Administration (FDA) under a full premarket approval (PMA). The PCR-based assay is optimised for low- to mid-throughput testing of CMV.

Qiagen GeneRead DNA FFPE Kit

The GeneRead DNA FFPE Kit provides a streamlined, easy-to-use procedure for efficient purification of DNA from formalin-fixed, paraffin-embedded (FFPE) tissue sections.

Qiagen REPLI-g WTA Single Cell Kit and REPLI-g Cell WGA & WTA Kit

The REPLI-g WTA Single Cell Kit and REPLI-g Cell WGA & WTA Kit enable transcriptomic NGS analysis from single cells and comparative genomic and transcriptomic analysis from the same small sample.

Qiagen therascreen EGFR RGQ PCR Kit

Qiagen has received approval by the US FDA to market the therascreen EGFR test as a companion diagnostic to guide the use of Boehringer Ingelheim’s targeted therapy GILOTRIF (afatinib) for treatment of metastatic NSCLC in patients whose tumours have certain EGFR gene mutations.

Qiagen mericon Salmonella spp. kit for food samples

Qiagen has announced that its mericon Salmonella spp. kit, in combination with the QIAsymphony RGQ automation platform, has received validation from the AOAC Research Institute, an independent third-party organisation that evaluates analytical methods for use in food safety and other testing.

Qiagen therascreen KRAS RGQ PCR kit

Qiagen has received FDA approval to market the therascreen KRAS RGQ PCR kit (therascreen KRAS test) to provide guidance on the use of Erbitux (cetuximab) as a treatment in patients with metastatic colorectal cancer.

Qiagen Rotor-Gene Q MDx PCR instrument and artus Infl A/B RG RT-PCR assay kit

Qiagen has released its real-time PCR (polymerase chain reaction) instrument, Rotor-Gene Q MDx and a compatible test for the detection of Influenza A/B, the artus Infl A/B RG RT-PCR Kit, for in vitro diagnostic use (IVD).

Qiagen QIAensemble Decapper automation system

The Qiagen QIAensemble Decapper automation system facilitates the handling of liquid-based cytology and various other types of liquid samples that are processed by clinical laboratories.

Qiagen JAK2 V617 companion diagnostic

Qiagen has entered into a partnership with Eli Lilly and will develop a PCR-based companion diagnostic running on the Rotor-Gene Q instrument that will provide both qualitative and quantitative results for JAK2 V617F.

Qiagen Multiplex PCR Plus Kit

The Qiagen Multiplex PCR Plus Kit has been designed for rapid and sensitive multiplex PCR that allows researchers to amplify several targets in one PCR run. The kit provides fast reaction times and comes with a preoptimised protocol, eliminating the need for optimisation and delivering reliable results on the first attempt.

Qiagen qBiomarker Somatic Mutation PCR Array System

The qBiomarker Somatic Mutation PCR Array System has been designed for rapid and accurate mutation profiling in basic research and drug discovery. The assays consist of collections of pathway or cancer-specific assays in 96- or 384-well plate formats with a number of pathways (EGFR, ErbB2, etc) and cancer types.

Qiagen Investigator Quantiplex Kit

The Investigator Quantiplex Kit has been designed to quickly confirm that forensic DNA samples contain sufficient DNA for genetic fingerprinting analysis. The kit quantifies the human DNA in the sample and establishes whether it contains inhibitors that may interfere with downstream applications.

Qiagen ScreenGel software

Qiagen has launched ScreenGel software for convenient DNA fragment and RNA analysis with the QIAxcel multicapillary gel electrophoresis systems. The software combines the highest possible flexibility for researchers with the ability for standardised and reproducible operations in routine laboratories.

Qiagen FFPE kits

Qiagen has launched several products that assist in the molecular analysis of formalin-fixed, paraffin-embedded (FFPE) tissue samples.

Qiagen QIAsymphony RGQ automated molecular testing system

QIAsymphony RGQ is a flexible automated solution for molecular testing. It incorporates all workflow steps from sample to detection.

SABiosciences RT2 Profiler PCR Arrays

SABiosciences has released several RT2 Profiler PCR Arrays for gene expression profiling in nephrotoxicity, hepatotoxicology, differentiation and embryonic stem cells markers as well as analysis of epigenetic modulators and enzymes. Covering more than 100 pathways, PCR arrays enable scientists to easily and accurately analyse the gene expression in research areas such as cancer, stem cells, biomarker discovery and immunology.

Qiagen GeneGlobe web portal

On the GeneGlobe web portal, users can explore and order gene and pathway specific products for a range of applications. For miRNA research, the miScript target protector is available for researchers doing functional analysis of miRNAs.

Qiagen Investigator PCR assays for human identification

The Investigator PCR assays for human identification have been released.

Biomatrica/Qiagen QIAsafe DNA blood products

Biomatrica and Qiagen have launched QIAsafe DNA Blood Products, the first dry blood storage available on a matrix based on Biomatrica’s SampleMatrix technology.

Qiagen Influenza A/H1N1 test kit

Qiagen has launch its Influenza A/H1N1 test and several updates to its activities in the global surveillance of the swine flu pandemic. The kit enables both the highly sensitive and specific detection of the novel Influenza A/H1N1 and all other known Influenza A and B virus strains. The test kit has been designed for use by governments and public health institutions.

Blood dry storage products

Biobanks are the intermediary between donors and research labs to ensure the safe, effective transfer of the biological information held in samples. The number of biobanks is increasing, as is the cost for power to store the samples at the appropriate refrigerated temperature. The current standard for storage is either at -20 or -70 °C. It is costly for biobanks not only to keep these samples cold, but also to house the refrigerators within their laboratories. New methods are being sought to allow storage at room temperature, thus reducing costs as well as being environmentally friendly. Qiagen has launched the QIAsafe DNA Blood Kit to provide easy transport and storage of whole blood at room temperature.

DNA kits

The QIAxcel DNA kits by QIAGEN replaces traditional gel analysis of DNA and RNA. Researchers can perform DNA fragment analysis in as little as ten minutes for 12 samples without the need for agarose gel preparation.

PCR cycler

The versatile Rotor-Gene Q real-time PCR cycler features a centrifugal rotary design. Each tube spins in a chamber of moving air, keeping all samples at precisely the same temperature during rapid thermal cycling. Detection is similarly uniform.

Automated PCR set-up

The QIAgility is a compact benchtop instrument enabling automated PCR set-up in a wide range of formats.

Rotor-Gene Q PCR cycler

The centrifugal rotary design of the Rotor-Gene Q makes it a precise, versatile real-time PCR cycler.

Intracellular RNA stabilisation

PreAnalytiX has received marketing clearance from the US Food and Drug Administration for the automation of the PAXgene Blood RNA System on the QIAcube. This clearance enables laboratories to automate an IVD purification method which is part of an integrated IVD blood collection method for intracellular RNA.

Standardised epigenetic kits

Qiagen has launched five additions to its EpiTect product line to help address the growing demand for standardised products for complete workflows in epigenetics.

Real-time PCR detection

The Rotor-Gene is a rotary real-time PCR cycler system used to detect real-time polymerase chain reaction (PCR) reactions, making specific sequences of DNA and RNA targets visible and quantifiable through amplification.

Molecular assay for K-ras

Qiagen has launched a test to determine mutations of the K-ras gene, which can better define which metastatic colorectal cancer (CRC) patients will benefit from treatment with epidermal growth factor receptor (EGFR) inhibiting monoclonal antibodies, such as Amgen’s Vectibix (panitumumab) and Imclone/Bristol-Myers Squibb’s Erbitux (cetuximab).

Slab gel analysis system

Analysis of DNA fragments, such as single- or multiplex PCR products and qualitative and quantitative RNA analysis, is easy and fast with the QIAxcel system. It fully automates sensitive, high-resolution capillary electrophoresis of up to 96 samples per run.

Micro RNA profiling

Qiagen has added to its portfolio of miRNA technologies with the introduction of the miScript System, which enables detection and quantification of miRNA, as well as mRNA and other small RNA, using SYBR Green-based, real-time PCR.

Fast PCR on any real-time cycler

QuantiFast Kits are claimed to deliver faster results in real-time PCR. With time savings of up to 60% on existing cyclers claimed, there is no need for hardware upgrades. In addition, no PCR optimisation is required, even if using previously established assays. Kits are available for SYBR Green or probe-based detection in PCR, two-step RT-PCR and one-step RT-PCR.

Human druggable genome

Qiagen has delivered its Human Druggable Genome siRNA Set V2.0 to the Scripps Research Institute in Florida. This second generation siRNA set from Qiagen enables efficient and effective gene silencing studies of 6992 potential human druggable targets. siRNAs are designed using the HiPerformance siRNA Design Algorithm, ensuring maximum silencing and minimum risk of non-specific effects.

Genome-wide RNAi library with cellular screening system

Xantos Biomedicine AG and Qiagen have announced their partnership for co-marketing Qiagen's proprietary TOM-amidite chemistry-based genome-wide RNAi products with Xantos' automated cell-based screening platform, XantoScreen. By combining the capabilities of both companies' platforms users will be able to rapidly perform gene analysis and unravel the function and role of genes that are relevant to their area of interest.

Automated genomic DNA isolation

BioSprint 15 and BioSprint 96 workstations and kits provide rapid and cost-efficient automated sample preparation - whatever the throughput needs. BioSprint 15 can process 1 to 15 samples or up to 96 samples can be processed with the BioSprint 96.


Monkey business pays off for award-winning microbiome researcher

Dr Michael Montague from the University of Pennsylvania has been declared the winner of the 2017 Microbiome Awards.

Qiagen acquires AmniSure International, adds assay to Point of Need portfolio

Qiagen NV has announced the acquisition of AmniSure International LLC, a privately owned Boston company that markets the AmniSure assay for determining whether a pregnant woman is suffering rupture of foetal membranes (ROM), a condition in which fluid leaks from the amniotic sac prematurely.



  • All content Copyright © 2021 Westwick-Farrow Pty Ltd